Magdalini Migkou (Magda Migkou)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Multiple Myeloma

Respiratory Syndrome Coronavirus

Aortic Stenosis

Epidermal Growth Factor Receptor

Top Venues

British journal of haematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology 204 (5) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, Panagiotis Malandrakis, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era. Diseases (Basel, Switzerland) 11 (3) (2023)
Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Maria Gavriatopoulou
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma. International journal of molecular sciences 24 (14) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Foteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, Maria Roussou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Asimina Papanikolaou, Maria Gavriatopoulou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy. British journal of haematology (2023)
Kostantinos Palamaris, Dimitrios Alexandris, Konstantinos Stylianou, Ioannis Giatras, Anastasios Stofas, Christina Kaitatzoglou, Magdalini Migkou, Dimitrios Goutas, Erasmia Psimenou, Eleni Theodoropoulou, Stamatios Theocharis, Nektarios Alevizopoulos, Efstathios Kastritis, Alexandros Gerakis, Harikleia Gakiopoulou
Immune Checkpoint Inhibitors' Associated Renal Toxicity: A Series of 12 Cases. Journal of clinical medicine 11 (16) (2022)
Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P Trougakos, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine. British journal of haematology (2021)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period. Annals of hematology 99 (6) (2020)
Efstathios Kastritis, Foteini Theodorakakou, Maria Roussou, Erasmia Psimenou, Charikleia Gakiopoulou, Smaragdi Marinaki, Anastasia Gatou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Ioannis Ntanasis-Stathopoulos, Ioannis V Kostopoulos, Evangelos Terpos, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance. British journal of haematology 193 (1) (2020)